Results 181 to 190 of about 87,184 (381)

From simplicity to complexity: A path to innovation in science and art. [PDF]

Proc Natl Acad Sci U S A
Goldstein JL.
europepmc   +1 more source

Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes. [PDF]

, 1985
Terry Reisine, Geneviève Rougon, Jacques Barbet, Hans‐Urs Affolter   +3 more
openalex   +1 more source

Mapping protein–protein interactions by mass spectrometry

Mass Spectrometry Reviews, EarlyView.
Abstract Protein–protein interactions (PPIs) are essential for numerous biological activities, including signal transduction, transcription control, and metabolism. They play a pivotal role in the organization and function of the proteome, and their perturbation is associated with various diseases, such as cancer, neurodegeneration, and infectious ...
Xiaonan Liu, Lawrence Abad, Lopamudra Chatterjee, Ileana M. Cristea, Markku Varjosalo   +4 more
wiley   +1 more source

Identification of cCMP- and cUMP-binding proteins using cCMP and cUMP coupled to agarose and biotin matrices. [PDF]

PLoS One
Wolter S, Neumann M, Koenig T, Hagedorn T, Schwede F, Pich A, Seifert R.   +6 more
europepmc   +1 more source

Agents that Activate Cyclic AMP-Dependent Protein Kinase Inhibit Explant Culture Growth and Mitotic Activity

, 1983
Kenneth M. Halprin, J. Richard Taylor, Victor Levine, Clyde Woodyard, Kenji Adachi, Mary Comerford   +5 more
openalex   +1 more source

Phosphorylation of yeast phosphatidylserine synthase in vivo and in vitro by cyclic AMP-dependent protein kinase. [PDF]

, 1988
Anthony J. Kinney, George Carman
openalex   +1 more source

Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay.

European Journal of Biochemistry, 1989
S. Davies, D. Carling, D. Hardie
semanticscholar   +1 more source

Rad51 at the Crossroads: Bridging DNA Repair, Tumorigenesis, and Immune Regulation

Med Research, EarlyView.
Therapeutic landscape of Rad51 in cancer treatment. Key elements include (1) DNA damage sources (PARPi, chemo/radiotherapy); (2) repair pathways (Rad51‐mediated HR); (3) intervention strategies (Rad51 inhibitors, CRISPR/Cas9); and (4) combination approaches (immunotherapy). The figure is created with BioRender.com.
Zhendong Qin, Mingjun Lu, Jingwei Guo, Chenyang Wang, Teng Ma   +4 more
wiley   +1 more source

The rise of AMPylation: from bacterial beginnings to modern implications in health and disease. [PDF]

Biochem Soc Trans
Mukherjee M, Sreelatha A.
europepmc   +1 more source

Activation of type I cyclic AMP-dependent protein kinases with defective cyclic AMP-binding sites.

, 1987
Robert A. Steinberg, Joanne L. Russell, Caroline Murphy, David A. Yphantis   +3 more
openalex   +1 more source